John Lo
About John Lo
John Lo, Ph.D., is the Chief Commercial Officer with a background in molecular biology and extensive experience in the biotechnology and pharmaceutical sectors.
Chief Commercial Officer Role
John Lo, Ph.D., currently serves as the Chief Commercial Officer. In this role, he oversees a wide range of commercial activities, guiding strategy and operations to enhance the company's market presence. His extensive experience in the biotechnology and pharmaceutical industries informs his approach to market access and product commercialization, positioning him as a critical leader within the organization.
Education and Expertise in Molecular Biology
John Lo holds a Ph.D. in molecular biology from the Massachusetts Institute of Technology (MIT). His academic background provides a strong foundation for his work in the biotechnology and pharmaceutical sectors. This expertise complements his roles in drug development, commercialization, and strategic planning across various healthcare domains, ensuring scientifically grounded decision-making processes.
Biotechnology and Pharmaceutical Industry Experience
John Lo has a long history of experience in the biotechnology and pharmaceutical industries. He has previously served as an advisor to multiple private and public stage biotechnology companies, helping shape their development and commercialization strategies. His roles have included senior vice president of worldwide hematology at Bristol Myers Squibb and corporate vice president of hematology and oncology at Celgene. These positions highlight his extensive knowledge and leadership within the sector.
Strategic Roles at Celgene and Novartis
At Celgene, John Lo served as corporate vice president, hematology and oncology, and co-chair of the Development Committee. He contributed to the growth of R&D pipelines and was instrumental in making multiple pivotal study investments. Additionally, he held various P&L roles at Novartis, providing him with a broad perspective on both operational and strategic aspects of the business. These roles underscore his ability to drive organizational growth and innovation.
Drug Launches and Market Impact
John Lo has successfully launched numerous drugs in the U.S. and globally. Notably, his efforts include the launch of Tagrisso in lung cancer and two cell therapies. His impactful work in drug commercialization demonstrates his proficiency in navigating complex regulatory environments and his ability to bring life-changing therapies to market. His experience further extends to head of global marketing and market access at AstraZeneca, emphasizing his capability to drive widespread adoption of pharmaceutical products.
Consulting and Strategic Advisory Experience
John Lo spent several years as an associate principal at McKinsey & Company, where he provided strategic consulting services. His tenure at McKinsey equipped him with valuable skills in strategic planning, market analysis, and organizational development. This experience has proven invaluable in his subsequent roles within the biotech and pharmaceutical industries, allowing him to translate strategic insights into actionable business plans.